15th European Headache Federation Congress

Topics

• CLINICAL
  • Cephalic and non-cephalic pains in adolescents and adults
  • Addiction and headache
  • Cluster headache
  • Chronic pain vs chronic migraine/headache
  • Headache and gender
  • Geography of chronic migraine, interval headache and medication overuse Imaging
  • Migraine as a risk factor for acute neurovascular disorders
  • Is migraine associated with structural brain changes?
  • Migraine is different in children vs adult
  • Migraine fluctuations overtime
  • Post-traumatic headache
  • Occipital headache
  • The comorbidity between migraine and epilepsy
  • Spontaneous intracranial hypotension
  • The problem with migraine triggers
• BASIC
  • Brainstem aura
  • Aura and CSD role in onset of headache or migraine
  • Genetic vs Environmental
  • CGRP and other peptides
  • Headache/migraine models in animals
  • Headache electrophysiology
  • Inflammation
  • Hypothalamus role in migraine
  • Neuroimmunology, headache and mAbs
  • Neurobiology of migraine
  • Psychobiologic growth of migraine alongside development
  • New models for headache research
  • Understanding migraine pathophysiology through anti-migraine drugs
  • The Blood Brain Barrier
  • Understanding novel anti-migraine molecule targets
• TREATMENT
  • Endocannabinoid system and marijuana science: clinical benefit
  • Emerging targets for treatment - apart from CGRP
  • Guidelines on mAbs in migraine
  • Expectation role in treatment
  • How to manage headaches in the elderly
  • Guidelines on OnabotulinumtoxinA in migraine
  • Market placement of migraine medications
  • Management of secondary headache disorders
  • Neuropharmacology of migraine
  • Neuromodulation
  • Physical therapies and expectative in headaches
  • Pharmacovigilance and personalized medicine: missing pages